Temelimab Biosimilar - Research Grade

Human

endogenous retrovirus

5mg/ml

IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

Human endogenous retrovirus envelope proteins are investigated for their roles in neuroinflammation and multiple sclerosis research. The reagent here is a non-therapeutic, unconjugated analog of temelimab, a recombinant monoclonal antibody recognizing an endogenous retroviral envelope protein, for research use only. It is manufactured to in vivo standards with low endotoxin and made in scalable milligram to gram quantities for high-throughput laboratories. Applications include envelope-protein binding functional assays, in vitro neuroinflammation screens, and in vivo models of demyelinating disease. Uniform, reproducible material supports robust experimental design at research scale. Dependable lot-to-lot consistency underpins reliable use across large and repeated experiments.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks